Search Within

Zsofia Kinga Stadler

  1. "Biostatistics Service"
Formats
  1. Journal Article (50)
  2. Meeting Abstract (27)
  3. Conference Paper (1)
  4. Miscellaneous (1)
  5. Research Letter (1)
Groups
  1. Biostatistics Service (80)
  2. Center for Pancreatic Cancer Research (80)
  3. Clinical Genetics Service (80)
  4. Department of Medicine (80)
  5. Epidemiology and Biostatistics (80)
  6. Population Sciences Research Program (80)

More Groups

People
  1. Kenneth Offit (31)
  2. Michael Berger (30)
  3. Diana Mandelker (27)
  4. Jinru Shia (27)
  5. Yelena Kemel (26)
  6. Mark Robson (23)

More People

Years
  1. 2024 (6)
  2. 2023 (12)
  3. 2022 (9)
  4. 2021 (13)
  5. 2020 (11)
  6. 2019 (7)

More Years

Publications
  1. Journal of Clinical Oncology (22)
  2. Cancer (6)
  3. Clinical Cancer Research (5)
  4. Cancer Discovery (3)
  5. Cancer Research (3)
  6. Gynecologic Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (26)
  2. American Association for Cancer Research (12)
  3. Elsevier Inc. (7)
  4. Wiley Blackwell (7)
  5. Oxford University Press (5)
  6. American Medical Association (4)

More Publishers

Results (80)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comprehensive morphological assessment of colorectal cancers characterized by The Cancer Genome Atlas (TCGA) identifies specific morphology-molecular alteration associations
    Meeting Abstract

    Shia, J. R.; Kuk, D.; Schultz, N.; Berger, M.; Middha, S.; Vakiani, E.; Hechtman, J.; Stadler, Z.; Weiser, M.; Gonen, M.; more...
    Laboratory Investigation (2016)

    Fulltext@MSK | Save
  • Phase II trial of veliparib (V) in patients (pts) with previously treated BRCA or PALB2-mutated (mut) pancreas adenocarcinoma (PC)
    Meeting Abstract

    Lowery, M. A.; Kelsen, D. P.; Smith, S. C.; Moore, M.; Kindler, H. L.; Golan, T.; Segal, A.; Hollywood, E.; Maynard, H.; Capanu, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase IB trial of cisplatin (C), gemcitabine (G), and veliparib (V) in patients with known or potential BRCA or PALB2-mutated pancreas adenocarcinoma (PC)
    Meeting Abstract

    O'Reilly, E. M.; Lowery, M. A.; Segal, M. F.; Smith, S. C.; Moore, M. J.; Kindler, H. L.; Golan, T.; Segal, A.; Salo-Mullen, E. E.; Hollywood, E.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Randomized phase II study of gemcitabine (G), cisplatin (C) with or without veliparib (V) (arms A, B) and a phase II single-arm study of single-agent veliparib (arm C) in patients with BRCA or PALB2-mutated pancreas adenocarcinoma (PC)
    Meeting Abstract

    O'Reilly, E. M.; Lowery, M. A.; Yu, K. H.; Capanu, M.; Stadler, Z. K.; Epstein, A. S.; Golan, T.; Segal, A.; Segal, M.; Salo-Mullen, E. E.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Assessment of SLX4 Mutations in Hereditary Breast Cancers
    Journal Article

    Shah, S.; Kim, Y.; Ostrovnaya, I.; Murali, R.; Schrader, K. A.; Lach, F. P.; Sarrel, K.; Rau-Murthy, R.; Hansen, N.; Zhang, L.; more...
    PLoS ONE (2013)

    Fulltext@MSK | Save
  • Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer
    Journal Article

    Domchek, S. M.; Jhaveri, K.; Patil, S.; Stopfer, J. E.; Hudis, C.; Powers, J.; Stadler, Z.; Goldstein, L.; Kauff, N.; Khasraw, M.; more...
    Cancer (2013)

    Fulltext@MSK | Save
  • Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer
    Journal Article

    Stadler, Z. K.; Salo-Mullen, E.; Patil, S. M.; Pietanza, M. C.; Vijai, J.; Saloustros, E.; Hansen, N. A. L.; Kauff, N. D.; Kurtz, R. C.; Kelsen, D. P.; more...
    Cancer (2012)

    Fulltext@MSK | Save
  • Risk of breast cancer (BC) after BRCA-mutation associated ovarian cancer (BRCA-OC): Memorial Sloan-Kettering Cancer Center (MSKCC) experience
    Meeting Abstract

    Jhaveri, K. L.; Patil, S.; Khasraw, M.; Bhatia, J.; Stadler, Z. K.; Kauff, N. D.; Hudis, C.; Offit, K.; Robson, M. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women
    Journal Article

    Comen, E.; Balistreri, L.; Gonen, M.; Dutra Clarke, A.; Fazio, M.; Vijai, J.; Stadler, Z.; Kauff, N.; Kirchhoff, T.; Hudis, C.; more...
    Breast Cancer Research and Treatment (2011)

    Fulltext@MSK | Save
  • Immunohistochemical staining for dna mismatch repair proteins in intestinal tract carcinoma: How reliable are biopsy samples?
    Journal Article

    Shia, J.; Stadler, Z.; Weiser, M. R.; Rentz, M.; Gonen, M.; Tang, L. H.; Vakiani, E.; Katabi, N.; Xiong, X.; Markowitz, A. J.; more...
    American Journal of Surgical Pathology (2011)

    Fulltext@MSK | Save